Health Care & Life Sciences » Pharmaceuticals | Jinling Pharmaceutical Co. Ltd.

Jinling Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,594
2,756
3,207
3,560
3,174
2,878
Cost of Goods Sold (COGS) incl. D&A
2,016
2,127
2,550
2,884
2,526
2,246
Gross Income
578
629
657
676
648
632
SG&A Expense
352
380
409
405
477
418
EBIT
222
247
248
271
170
210
Unusual Expense
2
2
6
6
4
8
Non Operating Income/Expense
3
35
51
5
23
138
Interest Expense
10
10
8
8
11
4
Pretax Income
237
300
317
274
206
356
Income Tax
52
60
67
60
45
73
Equity in Affiliates
5
5
12
8
12
6
Consolidated Net Income
190
245
262
222
173
289
Net Income
156
197
208
180
137
242
Net Income After Extraordinaries
156
197
208
180
137
242
Net Income Available to Common
156
197
208
180
137
242
EPS (Basic)
0.31
0.39
0.41
0.36
0.27
0.48
Basic Shares Outstanding
504
504
504
504
504
504
EPS (Diluted)
0.31
0.39
0.41
0.36
0.27
0.48
Diluted Shares Outstanding
504
504
504
504
504
504
EBITDA
302
331
351
380
288
334
Other Operating Expense
-
4
2
-
1
4
Non-Operating Interest Income
20
29
19
12
20
19
Minority Interest Expense
34
48
54
42
36
47

About Jinling Pharmaceutical Co.

View Profile
Address
Jinling Pharmaceutical Building
Nanjing Jiangsu 210009
China
Employees -
Website -
Updated 07/08/2019
Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It involves in the preparations, production, and sale of western medicine raw materials, biochemical products, pharmaceutical packaging products, medical instruments, healthy food, natural beverages, and medical equipment. The company was founded on September 8, 1998 and is headquartered in Nanjing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.